Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients

International Journal of Cancer

Volumn 81, Issue 3, 1999, Pages 325-329

  Persson, Irene ^a   Johansson, Inger ^a   Lou, Ya Ching ^b   Yue, Qun Ying ^c   Duan, Lian Shan ^d   Bertilsson, Leif ^c   Ingelman Sundberg, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Hospital of Cancer   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CHINA; CIGARETTE SMOKING; ETHNIC DIFFERENCE; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

EID: 0032958161     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19990505)81:3<325::aid-ijc2>3.0.co;2-s     Document Type: Article

References (20)

1. BARTSCH, H. and HIETANEN, E., The role of individual susceptibility in cancer burden related to environmental exposure. Environ. Hlth. Perspect., 104, (Suppl. 3), 569-577 (1996).
2. BROCKMOLLER, J., GROSS, D., KERB, R., DRAKOULIS, N. and ROOTS. I., Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class mu gene detected by polymerase chain reaction. Biochem. Pharmacol., 43, 647-650 (1992).
3. HASSETT, C., AICHER, L., SIDHU, J.S. and OMIECINSKI, C.J., Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. mol. Genet., 3, 421-428 (1994).
4. HAYASHI, S.-I., WATANABE, J., NAKACHI, K. and KAWAJIRI, K., Genetic linkage of lung cancer-associated MspI polymorphism with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J. Biochem., 110, 407-411 (1991a).
5. HAYASHI, S., WATANABE, J. and KAWAJIRI, K., Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIEI gene. J. Biochem., 110, 559-565 (1991b).
6. HECKBERT, S.R., WEISS, N.S., HORNUNG, S.K., EATON, D.L. and MOTULSKY, A.G., Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. J. nat. Cancer Inst., 84, 414-422 (1992).
7. HIRVONEN, A., HUSGAFVEL-PURSIAINEN, K., ANTTILA, S., KARJALAINEN, A. and VAINIO, H., The human CYP2EI gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis, 14, 85-88 (1993).
8. KIHARA, M., KIHARA, M. and NODA, K., Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYPIAI and GSTMI gene polymorphisms in a Japanese population. Carcinogenesis, 16, 2331-2336 (1995).
9. KIM, R.B., YAMAZAKI, H., CHIBA, K., O'SHEA, D., MIMURA, M., GUENGERICH, F.P., ISHIZAKI, T., SHIMADA, T. and WILKINSON, G.R., In vivo and in vitro characterization of CYP2EI activity in Japanese and Caucasians. J. Pharmarol. exp. Ther., 1, 4-11 (1996).
10. KIYOHARA, C., NAKANISHI, Y., INUTSUKA, S., TAKAYAMA, K., HARA, N., MOTOHIRO, A., TANAKA, K., KONO, S. and HIROHATA, T., The relationship between CYPIAI aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population. Pharmacogenetics, 8, 315-323 (1998).
11. LATHROP, M.G., Estimating genotype relative risks. Tissue Antigens, 22, 160-166 (1983).
12. NAKACHI, K., IMAI, K., HAYASHI, S. and KAWAJIRI, K., Polymorphisms of the CYPIAI and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53, 2994-2999 (1993).
13. NEBERT, D.W., INGELMAN-SUNDBERG, M. and DALY, A., Genetic epidemiology of environmental toxicity and cancer susceptibility, human allelic polymorphisms in drug metabolizing enzyme (DME) genes, their functional importance and nomenclature issues. Drug Metab. Rev. (1999). (In press).
14. OYAMA, T., KAWAMOTO, T., MIZOUE, T., SUGIO, K., KODAMA, Y. MITSUDOMI, T. and YASUMOTO, K., Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res., 17, 583-588 (1997).
15. PERSSON, I., JOHANSSON, I., BERGLING, H., DAHL, M.L., SEIDEGARD, J., RYLANDER, R., RANNUG, A., HOGBERG, J. and INGELMAN-SUNDBERG, M., Genetic polymorphism of cytochrome P4502EI in a Swedish population. Relationship to incidence of lung cancer. FEBS Lett., 319, 207-211 (1993).
16. PERSSON, I., JOHANSSON, I. and INGELMAN-SUNDBERG, M., In vitro kinetics of two human CYPIAI variant enzymes suggested to be associated with interindividual differences in cancer susceptibility. Biochem. biophys. Res. Comm., 231, 227-230 (1997).
17. RAAKA, S., HASSETT, C. and OMIECINSKI, J., Human microsomal epoxide hydrolase: 5′-flanking region genetic polymorphisms. Carcinogenesis, 3, 387-393 (1998).
18. SUN, G.F., SHIMOJO, N., PI, J.B., LEE, S. and KUMAGAI, Y., Gene deficiency of glutathione S-transferase mu isoform associated with susceptibility to lung cancer in a Chinese population. Cancer Lett., 113, 169-172 (1997).
19. WANG, S.Y., HU, Y.L., WU, Y.L., LI, X., CHI, G.B., CHEN, Y. and DAI, W.S., A comparative study of the risk factors for lung cancer in Guangdong, China. Lung Cancer, 14, S99-S105 (1996).
20. WU, X., AMOS, C.I., KEMP, B.L., SHI, H., JIANG, H., WAN, Y. and SPITZ, M.R., Cytochrome P450 2E1 Dral polymorphisms in lung cancer in minority populations. Cancer Epidemiol. Biomarkers Prevent., 7, 13-18 (1998).